OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) today announced it will host a live webcast to provide a summary of the Company’s data, including its flagship product Tarceva® (erlotinib), presented during the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando, FL. The webcast will be hosted by Colin Goddard, Ph.D., Chief Executive Officer of OSI Pharmaceuticals and OSI's Oncology Management Team. The webcast will begin at 7:30AM Eastern Time on Tuesday, June 2, 2009.
To access the live webcast via the internet, please log on to www.osip.com approximately 15 minutes before the start of the event to allow for any software downloads that may be necessary. Following the webcast, an archive will be available at the same address for fourteen days.
No comments:
Post a Comment